• Quotes
  • Shortcuts
The Executive's Internet
Wed, Aug 12th
editor corner icon Editor's Corner | Archive
Operations-driven sustainability: Optimizing operations can unlock simultaneous environmental and financial benefits. Patricia
icon
GoogleAmazonWikipedia
site of the day icon Site of the Day | Archive
FlightStats
Track real-time flight status, departures and arrivals, airport delays, and airport information using FlightStats Global Flight Tracker.


spacerspacer

 

 BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'fund Capital'. (Return)

Yahoo BusinessAug 12, 2020
Why Nio Has A Shot At Becoming The 'Tesla Of China'
Chinese electric vehicle manufacturer Nio Inc - ADR (NYSE: NIO) reported Tuesday with forecast-beating second-quarter results and issued a strong third-quarter outlook. The Nio Analysts: Piper Sandler analyst Alexander Potter reiterated a Neutral rating on Nio and increased the price target from $4 to $14.BofA Securities analyst Ming Hsun Lee reiterated a Buy rating and increased the price target from $17.40 to $18.Why Nio Shares Could Trade In Line With EV Peers: Nio's narrower-than-expected second-quarter loss is due to a higher gross margin, with the vehicle margin coming in at a historical high of 9.7% and several basis points higher than the 5% guidance, Potter said in a note.More importantly, the company guided to continued gross margin expansion in the third and fourth quarters thanks to lower battery costs, the analyst said.From skepticism concerning the company's ability to remain a going concern, Nio has come a long way from skepticism over whether it could stay in business, he said. The automaker boasts unique products and has a reliance on subsidies, which are two prerequisites for success, Potter said.With Nio raising capital in two funding rounds, including a secondary offering in June, there are no longer fears that the company may go out of business, the analyst said. The stock will therefore trade more in-line with peers, and not at a substantial discount to them, he said. View more earnings on NIOThe company will slowly reduce its reliance on partners for core capabilities such as self-driving systems, batteries a

MarketWatch MarketPulseAug 12, 2020
Biotech Inhibrx to offer 6 million shares in planned IPO, priced at $16 to $18 each
Biotech Inhibrx set terms for its initial public offering on Wednesday with plans to offer 6 million shares priced at $16 to $18 each. The company has applied to list on Nasdaq under the ticker "INBX." Jefferies, Evercore ISI, Credit Suisse and LifeSci Capital are underwriting the deal. Proceeds will be used to fund clinical research, for R&D and general corporate purposes. "We are a clinical-stage biotechnology company with a pipeline of novel biologic therapeutic candidates, developed using our protein engineering expertise and proprietary single domain antibody, or sdAb, platform," the company says in its prospectus.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.


TRENDING TAGS
stockTesla Split Market S&P futures
coronavirusVaccine latest Russia updates cases
pandemiccoronavirus during COVID-19 amid stores
TrumpHarris Tax TikTok Biden unemployment
Dowdown points S&P Market Stock
Stocksrecord Rally S&P making biggest
COVID-19vaccine world Russia Moderna amid
RecordS&P stocks Market Coronavirus close
reliefcoronavirus talks House White Mnuchin
economicpandemic Report Crisis Roundup recovery

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC